Introduction
Mumps disease is caused by Mumps virus (MV), which belongs to the genus Rubulavirus of the subfamily Paramyxovirinae in the family Paramyxoviridae. MV is antigenically monotypic and spreads by respiratory droplets. Mumps is a vaccine-preventable disease that is endemic in most parts of the world. [1] Mumps disease outbreak occurred in an unvaccinated population of Chikkahallivana village in Davangere district of Karnataka, India in January 2014. Most of the affected unimmunized population belonged to a worker community who opted out of scheduled vaccination. The disease was managed using provincial mumps control guidelines, including programmes for enhanced surveillance and public awareness, in the specific geographic affected region. After the outbreak resolved, we utilized clinical and laboratory a region. [3] The magnitude and epidemiology of mumps infection in India are poorly understood. There are few literatures available in PubMed related to mumps virus circulation in India. [11] [12] [13] [14] However, detailed investigations on sporadic cases or outbreak (s) of mumps are necessary to understand the circulation of wild type viruses in the context of the global epidemiology of mumps. [15, 16] This study describes diagnostic tests performed for lab confirmation of mumps cases from a village-Chikkahallivana of Karnataka state, India.
Materials and Methods

Study area
Chikkahallivana is a small village in Davangare district, Karnataka. The district headquarters of Davangare is located at National Highway-4 (Chennai to Mumbai National Highway), Chikkahallivana village is 40 kms away from the district of Davangare and has an estimated population of 364 being rural. The village dwelling setting has two lanes namely, Lane-1 and Lane-2.
Study design
A cross-sectional survey was carried out by three members from the National Institute of Virology, Bangalore Unit with technical support from state Government district medical officer and it was decided that any identified case will be provided necessary treatment at the earliest possible time.
Sampling
The Chikkahallivana village was covered under this study. The contact was made with the village members to seek their cooperation for the investigation. A total village was surveyed by an investigating team in village who reported having mumps cases. The standard case definition was used for diagnosis of mumps. A disease symptoms criteria was used to clinically identify the mumps cases.
A study subject was considered to have mumps if presented with one of the symptoms criteria and any of the minor criteria. [17] Only the clinical definition of mumps was considered as the index case was already evaluated by experts. [17] The household was a sampling unit and the villagers were extensively covered by house-to-house visits made by the teams. With regard to the uni-or bilateral parotitis or fever cases in the household in the last 3 weeks, if any such case was found, extensive information was collected, for that, study subject enquiries about mumps cases were made from the mothers or responsible persons. Information was collected regarding age, gender, Table-1 history of mumps in the last 3 weeks.
Samples were collected from a total of 31 patients. Distribution of the samples was 31 blood and 31 throat swabs. Throat swabs were collected in virus transport medium. All the samples were carried on cold chain to the laboratory for diagnosis, according to WHO guidelines for specimen collection of mumps virus detection. [18] 
Serological test
The blood samples were processed to have the best quality serum and further tested for Mumps IgM antibodies. The test was done with standard positive control using IgM ELISA kit (Calbiotech, CA) as per the protocol. The kit is used for qualitative detection and quantitative determination of specific IgM antibodies to Mumps virus in human serum.
Molecular diagnosis
Total RNA was extracted from 140 μl of throat swab and blood samples using a QIAmp viral RNA kit (Qiagen, Valencia, CA) according to the manufacturer's protocol. RNA was eluted in 50 μl of nuclease free water. For the conventional PCR gel-based platform, a minimum of one standard positive control RNA and one negative control along with samples of target RNA included.
We used diagnostic RNA virus based nested reverse-transcriptase PCR (RT-PCR) to detect mumps virus from clinical samples. [19] A precautions were considered to prevent cross-contamination.
First round of RT-PCR was done using a standard primer pairs (PRV1 forward primer 5'-CGCGTGGTCTACGGGGACACGGA-3' and PRV1 reverse primer 5'-ATGACGCC GATGTACTTCTTCTT-3') to amplify a 600 bp fragment in the SH gene which included the 456 bp amplicon recommended for genotyping. [19] PCR conditions for RT-PCR were reverse transcription step at 42°C for 45 min; followed by 94°C for 2 min for pre-denaturation and denaturation at 94°C for 1 min, annealing at 47°C for 1 min and extension 68°C for 2 min, and an extension at 72°C for 7 min for 35 cycles. Thermocycling was done in a PCR system (Applied Biosystems, Foster City, CA) without an oil overlay.
The second PCR round was performed including 1 μl of undiluted first PCR product as template in a reaction containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 200 μM each dNTP, 2.5 mM MgCl 2 , 2.5 units of Taq polymerase (Qiagen, Germany), 10 pmol each of internal control primers PRV2-(5'-GGGACACGGACTCGGTCTTC-3') and PRV2-(5'-CCGGAAGG TCTTCTCGCACTC-3') and 10 pmol each of forward and reverse primers. Nested PCR assays were subjected to an initial cycle of 94°C for 2 min and 30 cycles of 94°C for 1 min, 50°C for 1 min and 72°C for 1 min, followed by final incubation at 72°C for 5 min. After amplification, 10 μl portion of each product was analyzed by agarose gel electrophoresis utilizing 2.0% agarose gel (Sigma Aldrich) and gels were stained with ethidium bromide at 5 μg/ml and visualized by Gel documentation system (Bio-Rad, USA) using the software Quantity One version 4.6.3 to determine the band size. A 1 kb DNA ladder (Invitrogen, Life Technologies) was used as a molecular ladder.
Nucleotide sequencing for genotyping and phylogenetic analysis
The positive mumps viruses of second round PCR products of representative samples were sequenced by dideoxy terminator sequencing method and comparison of the nucleotide sequence was performed using the NCBI BLAST programme with the GenBank database. Mumps SH-gene sequence obtained in this study confirmed with both strands and aligned with WHO reference SH-gene sequence [10] using software ClustalW version 1.83. The viral-DNA sequence was also deposited in Genbank (http:// www.ncbi.nlm.nih.gov). 
Results
Serological investigation of the clinical samples showed 18 children (58%) positive for mumps IgM antibodies, from the total 31 samples subjected to serological analysis. In majority, children below the age of 10 years were found positive for mumps IgM antibodies. Total of six children were found positive between the age of 1-6 years, 11 children between the age of 7-13 years and one positive case of 30 age. Out of total 18 children, five boys and 13 girls were found positive for the mumps IgM antibodies Table 1 . The results revealed girls were predominantly affected with the mumps disease as compare to boys [ Figure 2 ].
Molecular assay results
Mumps virus was detected from throat swab, using nested RT-PCR and PCR product size were 448bp with primers targeting the SH genes [ Figure 3 ].
Out of 31 cases, 7 (22%) were confirmed by RT-PCR. All acute phase specimens are positive by RT-PCR. The age group involved was 1-15 yrs. It included two boys and five girls positive with RT-PCR results.
Genotyping results
Sequence information revealed that the sequence from infected mumps virus share 99% homology with Mumps virus strain MuVi/Chennai.IND/45.12 small hydrophobic protein (SH) gene, complete cds having Genbank accession no. KC429765 from Chennai. Sequencing of the SH gene identified outbreak strain as genotype C, was named as MuVi/Davangare. IND and deposited in Genbank (Acc. No. KJ468460, KJ468461) which was consistent with other outbreaks in India. [11] [12] [13] The phylogeny obtained by analysis of representative strains of all genotypes and our sample sequences allowed quick and easy differentiation of the corresponding genotype [ Figure 4 ]. Phylogenetic tree of mumps virus genotypes based on the 316 nucleotides of the entire small hydrophobic gene: Our isolated virus sequences were matched with WHO reference strains. Neighbour-joining methods of MEGA 5 programme were used. [20] The parameter employed was Kimura 2-parameter model and the robustness of the internal branches was determined by 1000 bootstrap replications. The horizontal length of the bar denotes percentage difference between sequences (see scale at bottom) and the bootstrap numbers (%) are given at each node.
The clustering pattern clearly divides two groups, each representing a genotype group included in this study. The bootstra P values ranges from 62-99 for genotype A, F, J and 11-99 for C, E, D, K, M, H, L, I, B, N and G representing of diversity in accession of these mumps strain. The sequence identity of C genotypes with the WHO reference genotype C was ranged from 39 to 99. MuVi/Davangare isolate is close to MuVi/Chennai stain. Furthermore, articles reporting sets of data show temporal changes in the dominant genotype, as well as co-circulation of genotypes in the same or in neighbouring states. According to our findings, these different lineages showed within genotype 'C' that the virus responsible for an outbreaks in South India was similar as earlier reported in India. [11] [12] [13] 
Discussion
The use of vaccine in developed countries successfully reduced mumps virus infection, though outbreaks are often reported. Due to absence of effective vaccination programmes, mumps is still a major health problem in several developing countries. Mumps disease burden in India is still not completely understood. Few published reports indicate more occurrence of the disease in children of the age-group 5-9 years. [4, 5] In the present study it was shown that mumps virus exhibited a positive laboratory result is defined as either: IgM positive or virus detection by RT-PCR. Suspected mumps cases were confirmed by systematic laboratory testing which included IgM test, RT-PCR and sequencing analysis.
A positive IgM test result indicates current infection or reinfection. The detection of mumps virus by RT-PCR method confirms the outbreak due to mumps virus and sequencing analysis further revealed circulation of 'C' genotype as reported earlier in South India.
